TGTX
TG Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$55.85
−1.52%Forward multiples
Based on analyst estimates
- P/E forward
- 29.48x
- P/E 2026E
- 55.73x
- P/E 2027E
- 19.54x
- P/E 2028E
- 15.23x
- P/S forward
- 7.72x
Trailing multiples
Trailing twelve months
- P/E TTM
- 18.34x
- PEG TTM
- —
- Price / book
- 14.15x
- Price / sales
- 10.69x
- Price / cash flow
- —
Enterprise value
- Enterprise value
- $8.8B
- EV / sales
- 10.94x
- EV / EBITDA
- 65.22x
- EV / EBIT
- 64.19x
- Market cap
- $8.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026